NeuroSense Therapeutics L...

0.96
0.04 (4.51%)
At close: Apr 03, 2025, 1:36 PM

NeuroSense Therapeutics Ltd. Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
-11.28M -12.34M -4.04M -2.83M -1.22M
97K 89K 3K 3K n/a
1.54M 5.11M 4.16M 2.06M 611K
928K 291K 289K 37K 6K
1.3M -1.19M 791K -2K 591K
-2.01M n/a -2.72M 2K n/a
1.91M 750K 273K 69K 29K
-8.45M -7.59M -1.54M -695K -582K
-29K -70K -17K -9K -7K
3K n/a n/a n/a n/a
n/a -3.5M n/a n/a -19K
3.5M n/a n/a n/a n/a
-6K 29K n/a n/a -19K
3.47M -3.54M -17K -9K -26K
n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a
-75K 3.69M 2.04M n/a -3K
3.9M 3.69M 11.9M 508K 1.42M
-903K -7.52M 10.36M -196K 809K
-8.48M -7.66M -1.56M -704K -589K